Oral presentation at the American College of Rheumatology on CR10049, the first intra-articular, long-acting Src family kinase inhibitor for the inflammatory osteoarthritis (OA) phenotype
Press Release Monza (Italy) – Rottapharm Biotech, a research company dedicated to the discovery and development of innovative drugs, today announces that preclinical data supporting the… Read More »Oral presentation at the American College of Rheumatology on CR10049, the first intra-articular, long-acting Src family kinase inhibitor for the inflammatory osteoarthritis (OA) phenotype